{
    "code": "52028311",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52028311",
    "time": "2024-02-01 19:38:39",
    "許可證字號": "衛部藥輸字第028311號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/06\/21",
    "發證\/登錄日期": "111\/06\/21",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202831103",
    "中文品名": "恩瑞比膠囊",
    "英文品名": "Inrebic Capsule",
    "適應症": "適用於未曾接受Janus激酶抑制劑(JAK inhibitor)治療或曾接受ruxolitinib治療，中度風險或高風險之骨髓纖維化(包括原發性骨髓纖維化、真性紅血球增多症後骨髓纖維化、或血小板增多症後骨髓纖維化)成人病人",
    "劑型": "130膠囊劑",
    "包裝": "8-1000顆塑膠瓶裝(HDPE)",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新成分;",
    "監視期限": "116\/06\/21",
    "主成分略述": "Fedratinib dihydrochloride monohydrate",
    "限制項目": "02輸　入 5G小兒\/少數嚴重疾病藥品認定",
    "申請商名稱": "台灣必治妥施貴寶股份有限公司",
    "申請商地址": "臺北市松山區健康路156號4樓、5樓",
    "主製造廠": [
        {
            "製造廠名稱": "CELGENE INTERNATIONAL SARL",
            "製造廠廠址": "ROUTE DE PERREUX 1 2017 BOUDRY SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013004220",
            "成分名稱": "Fedratinib dihydrochloride monohydrate",
            "含量描述": "(equivalent to 100 MG fedratinib)",
            "含量": "117.3000000000",
            "單位": "MG"
        }
    ]
}